2m 2m 2m 2m 2m 2m 2m
PRELUDE THERAP (PRLD)
NASDAQ
$4.55-$0.04 (-0.96%)
Price as of Sep 11, 2026 7:57 PM EDT- $298.7MMarket Cap
- 306.19%1-Year Change
- BiotechnologyIndustry
PRELUDE THERAP (PRLD)
$4.55-$0.04 (-0.96%)
Earnings Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 45.43% | ||
12-Month Momentum | 373.55% | ||
3-Month Risk Adjusted Momentum | 121.97% | ||
12-Month Risk Adjusted Momentum | 189.10% |
True Yield
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | PRLD | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |